These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 735244)

  • 1. [Indications and results of an additional differentiated pharmacotherapy of obesity].
    Kucher E
    Z Gesamte Inn Med; 1978 Oct; 33(20):749-53. PubMed ID: 735244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
    Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y
    Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term effects of weight reduction on body weight and metabolic parameters in adipose non-diabetics and adipose maturity-onset diabetics].
    Schneider H; Zschornak M; Neumann I; Haller H
    Z Gesamte Inn Med; 1981 Apr; 36(7):301-4. PubMed ID: 7281831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of reducing--revisited.
    Blackburn GL; Read JL
    Postgrad Med J; 1984; 60 Suppl 3():13-8. PubMed ID: 6240029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].
    Héraïef E
    Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity in hypertension: effects on prognosis and treatment.
    Kaplan NM
    J Hypertens Suppl; 1998 Jan; 16(1):S35-7. PubMed ID: 9534095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
    Sindelka G; Skrha J; Hilgertová J; Justová V
    Cas Lek Cesk; 1997 Sep; 136(17):530-2. PubMed ID: 9441013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of long-term biguanide therapy as a preventive measure in protodiabetes].
    Neumann VI; Michaelis D; Schulz B; Wulfert P; Heinke P
    Endokrinologie; 1975 Feb; 64(3):290-8. PubMed ID: 1227826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of morbid obesity with intragastric balloon in association with diet.
    Doldi SB; Micheletto G; Perrini MN; Librenti MC; Rella S
    Obes Surg; 2002 Aug; 12(4):583-7. PubMed ID: 12194556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes.
    Krotkiewski M
    Scand J Rehabil Med Suppl; 1983; 9():55-70. PubMed ID: 6372078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.
    Dessì-Fulgheri P; Sarzani R; Rappelli A
    J Nephrol; 1998; 11(6):296-9. PubMed ID: 10048495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenetic relationships between obesity and maturity-onset diabetes].
    Spanár E; Uhrín P; Levcík A; Záhradný V
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 170-1. PubMed ID: 930174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intensified therapy of newly detected maturity onset diabetes].
    Pissarek D; Panzram G; Lundershausen R; Adolph W; Senf L
    Endokrinologie; 1980 Jan; 75(1):105-15. PubMed ID: 6989592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.